Single agent versus combination chemotherapy for metastatic breast cancer

Author:

Carrick Sue1,Parker Sharon2,Thornton Charlene3,Ghersi Davina4,Simes John5,Wilcken Nicholas6

Affiliation:

1. Twins Research Australia, Melbourne School of Population and Global Health; The University of Melbourne; Melbourne Australia

2. Centre for Primary Health Care and Equity; University of NSW; Sydney Australia

3. School of Medicine; University of Western Sydney; Penrith Australia

4. Research Policy and Translation; National Health and Medical Research Council; Canberra Australia

5. NHMRC Clinical Trials Centre; The University of Sydney; Camperdown Australia

6. Medical Oncology; Crown Princess Mary Cancer Centre; Westmead Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference94 articles.

1. A phase 2 evaluation of 1 (2 chloroethyl) 3 (4 methylcyclohexyl) 1 nitrosourea (NSC 95441) in;Ahmann;Cancer Research,1974

2. The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy;Ahmann;Journal Clinical Oncology,1987

3. Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer;Ahmann;Cancer Chemotherapy Reports - Part 1,1974

4. The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy;Ahmann;J Clin Oncol,1987

5. Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer;Ahmann;Cancer Chemotherapy Reports,1974

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3